Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Biolase Inc (BIOL)

Biolase Inc (BIOL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 20,590
  • Shares Outstanding, K 50,342
  • Annual Sales, $ 37,800 K
  • Annual Income, $ -17,860 K
  • 60-Month Beta 2.08
  • Price/Sales 0.54
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.72
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 08/13/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend 0.010 on 06/24/05
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.20
  • Number of Estimates 1
  • High Estimate -0.20
  • Low Estimate -0.20
  • Prior Year -0.15
  • Growth Rate Est. (year over year) -33.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3708 +13.13%
on 07/06/20
0.5780 -27.42%
on 07/21/20
+0.0225 (+5.67%)
since 07/02/20
3-Month
0.3650 +14.93%
on 05/14/20
0.8200 -48.84%
on 06/05/20
+0.0037 (+0.89%)
since 05/01/20
52-Week
0.2110 +98.82%
on 04/06/20
1.6500 -74.58%
on 08/09/19
-1.2205 (-74.42%)
since 08/02/19

Most Recent Stories

More News
Medical Laser Market to Exhibit CAGR of 13.9% by 2027; Accountable to Rising Prevalence of Coronary Artery Diseases: Fortune Business Insights(TM)

The global medical lasers market is anticipated to gain impetus from the rising demand for aesthetic laser procedures, especially in the developing nations. Laser therapy is a medical treatment that uses...

BIOL : 0.4227 (+3.35%)
ELXMF : 0.2750 (-14.06%)
IRIX : 1.96 (-2.97%)
TOPCF : 6.5550 (-13.98%)
BIOLASE Announces Closing Of Oversubscribed Rights Offering

, /PRNewswire/ --  (NASDAQ: BIOL), a global leader in dental lasers, further strengthened its balance sheet today as it closed the Company's previously announced rights offering (the "Offering")....

BIOL : 0.4227 (+3.35%)
BIOLASE Announces Expiration Of Oversubscribed Rights Offering

, /PRNewswire/ --   (NASDAQ: BIOL), a global leader in dental lasers, announced today the expiration of the Company's rights offering, which was oversubscribed.  The subscription period for its...

BIOL : 0.4227 (+3.35%)
Landmark Head-to-Head Study Published in Journal of Periodontology Concludes That BIOLASE REPAIR® Perio Protocol is Superior for Procedure Time and Patient-Reported Outcomes

, /PRNewswire/ --  (NASDAQ: BIOL), the global leader in dental lasers, today announced data published in the from a clinical trial conducted at ™. Designed to meet the stringent American Association...

BIOL : 0.4227 (+3.35%)
BIOLASE to Present at COVID-19 Webinar Hosted by Maxim Group on July 16, 2020

, /PRNewswire/ -- (NASDAQ:), the global leader in dental lasers, announced today that BIOLASE CEO Todd Norbe has been invited to participate in a panel discussion on Re-Engaging Medical Practices in...

BIOL : 0.4227 (+3.35%)
BIOLASE's Epic Hygiene Laser Meets Guidelines to Minimize Risk of COVID-19 Transmission

, /PRNewswire/ --  (NASDAQ: BIOL), the global leader in dental lasers, announced today that the Epic Hygiene dental laser meets recent guidance from the. Ultrasonic scalers create a visible water spray...

BIOL : 0.4227 (+3.35%)
BIOLASE, Inc. Announces Commencement of Rights Offering Subscription Period

, /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), a global leader in dental lasers, today announced that the subscription period for the rights offering has commenced. If exercising subscription rights...

BIOL : 0.4227 (+3.35%)
Paragonix Technologies Announces Appointment of Alexander K. Arrow, MD, CFA to the Board of Directors

Paragonix Technologies, Inc. a commercial stage company and leader in organ preservation and transport technology, today announced that Alexander K. Arrow, MD, CFA has joined its Board of Directors.

BIOL : 0.4227 (+3.35%)
BIOLASE, Inc. Informs Stockholders of Key Dates and Terms Related to Announced Rights Offering

, /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), a global leader in dental lasers, today provided an informational update to stockholders regarding its proposed rights offering and the expected key dates...

BIOL : 0.4227 (+3.35%)
BIOLASE, Inc. Announces Closing of $6.9 Million Registered Direct Offering Priced At-The-Market

, /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced the closing on of its previously announced registered direct offering of approximately of its common...

BIOL : 0.4227 (+3.35%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade BIOL with:

Business Summary

Biolaw Technology, Inc. is the world's leading dental laser company, is a medical technology company that develops, manufactures and markets lasers and related products focused on technologies that advance the practice of dentistry and medicine. The Company's products incorporate patented and patent...

See More

Key Turning Points

2nd Resistance Point 0.4321
1st Resistance Point 0.4205
Last Price 0.4227
1st Support Level 0.4002
2nd Support Level 0.3915

See More

52-Week High 1.6500
Fibonacci 61.8% 1.1003
Fibonacci 50% 0.9305
Fibonacci 38.2% 0.7607
Last Price 0.4227
52-Week Low 0.2110

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar